tiprankstipranks
Pieris Pharmaceuticals (PIRS)
NASDAQ:PIRS

Pieris Pharmaceuticals (PIRS) Stock Price & Analysis

574 Followers

PIRS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.14 - $1.29
Previous Close$0.19
Volume468.88K
Average Volume (3M)592.22K
Market Cap
$19.15M
Enterprise Value-$13.37M
Total Cash (Recent Filing)$44.81M
Total Debt (Recent Filing)$12.29M
Price to Earnings (P/E)-0.6
Beta1.19
May 08, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.35
Shares Outstanding98,851,927
10 Day Avg. Volume1,942,982
30 Day Avg. Volume592,218
Standard Deviation0.25
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.61
Price to Sales (P/S)3.27
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.27
Enterprise Value/Gross Profit-0.52
Enterprise Value/Ebitda-1.12
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

4.13%1.93%32.50%61.44%
32.50% Other Institutional Investors
61.44% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

PIRS FAQ

What was Pieris Pharmaceuticals’s price range in the past 12 months?
Pieris Pharmaceuticals lowest stock price was $0.14 and its highest was $1.29 in the past 12 months.
    What is Pieris Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Pieris Pharmaceuticals’s upcoming earnings report date?
    Pieris Pharmaceuticals’s upcoming earnings report date is May 08, 2024 which is in 40 days.
      How were Pieris Pharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is Pieris Pharmaceuticals overvalued?
      According to Wall Street analysts Pieris Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Pieris Pharmaceuticals pay dividends?
        Pieris Pharmaceuticals does not currently pay dividends.
        What is Pieris Pharmaceuticals’s EPS estimate?
        Pieris Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Pieris Pharmaceuticals have?
        Pieris Pharmaceuticals has 98,851,930 shares outstanding.
          What happened to Pieris Pharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Pieris Pharmaceuticals?
          Among the largest hedge funds holding Pieris Pharmaceuticals’s share is Platinum Investment Management. It holds Pieris Pharmaceuticals’s shares valued at N/A.
            ---

            Company Description

            Pieris Pharmaceuticals

            Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Advaxis
            Agios Pharma
            Crispr Therapeutics AG
            Curis
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis